Lundbeck
HLUN-B.CO
#2769
Rank
โ‚ฌ4.13 B
Marketcap
4,30ย โ‚ฌ
Share price
-0.12%
Change (1 day)
-3.06%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): 0,33ย โ‚ฌ

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is 0,32ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of 0,24ย โ‚ฌ a decrease over its 2021 EPS that were of 0,54ย โ‚ฌ.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)0,33ย โ‚ฌ37.88%
20220,24ย โ‚ฌ-55.47%
20210,54ย โ‚ฌ-51.83%
20201,13ย โ‚ฌ-28.01%
20191,57ย โ‚ฌ-44.08%
20182,81ย โ‚ฌ51.94%
20171,85ย โ‚ฌ126.64%
20160,82ย โ‚ฌ-120.84%
2015-3,91ย โ‚ฌ5622.18%
2014-0,06841ย โ‚ฌ-110.03%
20130,68ย โ‚ฌ-28.08%
20120,95ย โ‚ฌ-52.1%
20111,98ย โ‚ฌ-1.31%
20102,01ย โ‚ฌ15.61%
20091,73ย โ‚ฌ